Oral Semaglutide Cuts CV Events 14% in Type 2 Diabetes 03/28/26
Welcome to Cardiology Today â Recorded March 28, 2026. This episode summarizes 5 key cardiology studies on topics like oral anticoagulation and caregiver self-care. Key takeaway: Oral Semaglutide Cuts CV Events 14% in Type 2 Diabetes.
Article Links:
Article 1: Supporting Family Caregiver Health in Heart Failure: Longitudinal Associations Between Heart Failure Caregiver Self-Care and Patient Hospitalizations. (Journal of cardiac failure)
Article 2: Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial. (JAMA cardiology)
Article 3: Incidence, Predictors, Management, and Clinical Impact of Major Bleeding Following Left Atrial Appendage Occlusion: The Amulet IDE Randomized Clinical Trial. (JAMA cardiology)
Article 4: Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study. (Heart (British Cardiac Society))
Article 5: Aortic coarctation and long-term morbidity after arterial switch operation: a multicentre international cohort study. (Heart (British Cardiac Society))
Full episode page: https://podcast.explainheart.com/podcast/oral-semaglutide-cuts-cv-events-14-in-type-2-diabetes-03-28-26/
đ Featured Articles
Article 1: Supporting Family Caregiver Health in Heart Failure: Longitudinal Associations Between Heart Failure Caregiver Self-Care and Patient Hospitalizations.
Journal: Journal of cardiac failure
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41895678
Summary: Prior research demonstrated that health coaching reduces heart failure caregiver stress and improves caregiver self-care behaviors. This randomized controlled trial assessed the longitudinal associations between improved caregiver self-care and heart failure patient hospitalization outcomes. The study identified how changes in caregiver well-being influenced patient clinical trajectories, underscoring the critical role of caregiver support in patient health.
Article 2: Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial.
Journal: JAMA cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41879791
Summary: The S. O. U. L. randomized clinical trial found that once-daily oral semaglutide reduced the risk of major adverse cardiovascular events by 14 percent compared to placebo. This significant benefit occurred in individuals with type two diabetes and atherosclerotic cardiovascular disease or chronic kidney disease receiving standard of care. This secondary analysis demonstrated the specific changes oral semaglutide induced in long-term cardiovascular risk factors within this high-risk patient group.
Article 3: Incidence, Predictors, Management, and Clinical Impact of Major Bleeding Following Left Atrial Appendage Occlusion: The Amulet IDE Randomized Clinical Trial.
Journal: JAMA cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41879767
Summary: Left atrial appendage occlusion is a critical intervention for patients with contraindications to oral anticoagulation and an increased risk of major bleeding. The Amulet I. D. E. randomized clinical trial meticulously identified the incidence, key predictors, and effective management strategies for major bleeding following left atrial appendage occlusion. This study, involving 1878 randomized patients comparing the Amulet with the Watchman devices, also determined the clinical impact of these bleeding events on patient outcomes.
Article 4: Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study.
Journal: Heart (British Cardiac Society)
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41887758
Summary: Many patients with coronary heart disease exhibit blood pressure above guideline targets, even with ongoing treatment. European guidelines offer conflicting recommendations regarding patients with on-treatment blood pressure below target, with the 2023 European Society of Hypertension guidelines issuing a class three recommendation to proactively avoid blood pressure below target. The I. N. T. E. R. A. S. P. I. R. E. study established the prevalence and characteristics of patients with coronary heart disease whose blood pressure fell below target levels.
Article 5: Aortic coarctation and long-term morbidity after arterial switch operation: a multicentre international cohort study.
Journal: Heart (British Cardiac Society)
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40701798
Summary: Cardiovascular interventions and complications commonly occur after arterial switch operation in patients with dextro-transposition of the great arteries. While complex anatomy, such as ventricular septal defects, is often associated with these outcomes, the independent role of aortic coarctation remained unclear. This multicenter international cohort study analyzed 502 adults from the E. P. O. C. H. A. S. O. registry, precisely defining the long-term morbidity associated with aortic coarctation following arterial switch operation, independent of other complex anatomical factors.
đ Transcript
Today’s date is March 28, 2026. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Supporting Family Caregiver Health in Heart Failure: Longitudinal Associations Between Heart Failure Caregiver Self-Care and Patient Hospitalizations. Prior research demonstrated that health coaching reduces heart failure caregiver stress and improves caregiver self-care behaviors. This randomized controlled trial assessed the longitudinal associations between improved caregiver self-care and heart failure patient hospitalization outcomes. The study identified how changes in caregiver well-being influenced patient clinical trajectories, underscoring the critical role of caregiver support in patient health.
Article number two. Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial. The S. O. U. L. randomized clinical trial found that once-daily oral semaglutide reduced the risk of major adverse cardiovascular events by 14 percent compared to placebo. This significant benefit occurred in individuals with type two diabetes and atherosclerotic cardiovascular disease or chronic kidney disease receiving standard of care. This secondary analysis demonstrated the specific changes oral semaglutide induced in long-term cardiovascular risk factors within this high-risk patient group.
Article number three. Incidence, Predictors, Management, and Clinical Impact of Major Bleeding Following Left Atrial Appendage Occlusion: The Amulet IDE Randomized Clinical Trial. Left atrial appendage occlusion is a critical intervention for patients with contraindications to oral anticoagulation and an increased risk of major bleeding. The Amulet I. D. E. randomized clinical trial meticulously identified the incidence, key predictors, and effective management strategies for major bleeding following left atrial appendage occlusion. This study, involving 1878 randomized patients comparing the Amulet with the Watchman devices, also determined the clinical impact of these bleeding events on patient outcomes.
Article number four. Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study. Many patients with coronary heart disease exhibit blood pressure above guideline targets, even with ongoing treatment. European guidelines offer conflicting recommendations regarding patients with on-treatment blood pressure below target, with the 2023 European Society of Hypertension guidelines issuing a class three recommendation to proactively avoid blood pressure below target. The I. N. T. E. R. A. S. P. I. R. E. study established the prevalence and characteristics of patients with coronary heart disease whose blood pressure fell below target levels.
Article number five. Aortic coarctation and long-term morbidity after arterial switch operation: a multicentre international cohort study. Cardiovascular interventions and complications commonly occur after arterial switch operation in patients with dextro-transposition of the great arteries. While complex anatomy, such as ventricular septal defects, is often associated with these outcomes, the independent role of aortic coarctation remained unclear. This multicenter international cohort study analyzed 502 adults from the E. P. O. C. H. A. S. O. registry, precisely defining the long-term morbidity associated with aortic coarctation following arterial switch operation, independent of other complex anatomical factors.
Thank you for listening. Don’t forget to subscribe.
đ Keywords
oral anticoagulation, caregiver self-care, long-term morbidity, atherosclerotic cardiovascular disease, left atrial appendage occlusion, hypertension, dextro-transposition of the great arteries, guideline recommendations, aortic coarctation, type two diabetes, patient hospitalization, blood pressure targets, coronary heart disease, INTERASPIRE study, arterial switch operation, major bleeding, chronic kidney disease, longitudinal associations, major adverse cardiovascular events, heart failure, congenital heart disease, oral semaglutide, cardiovascular risk factors, Watchman device, health coaching, Amulet device.
âšī¸ About
Concise summaries of cardiovascular research for professionals.
Subscribe âĸ Share âĸ Follow